Cibc World Market Inc. Lowers Stock Position in Corteva, Inc. $CTVA

Cibc World Market Inc. lowered its position in shares of Corteva, Inc. (NYSE:CTVA) by 72.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 57,389 shares of the company’s stock after selling 154,590 shares during the quarter. Cibc World Market Inc.’s holdings in Corteva were worth $3,847,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. JPL Wealth Management LLC purchased a new position in shares of Corteva in the 3rd quarter worth about $25,000. Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the 3rd quarter worth about $29,000. Basepoint Wealth LLC purchased a new position in shares of Corteva in the 4th quarter worth about $30,000. Jackson Grant Investment Advisers Inc. raised its position in shares of Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares during the last quarter. Finally, Measured Wealth Private Client Group LLC purchased a new position in Corteva in the 3rd quarter worth about $33,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Down 1.3%

CTVA stock opened at $76.04 on Tuesday. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The company has a market capitalization of $50.86 billion, a price-to-earnings ratio of 44.73, a PEG ratio of 2.36 and a beta of 0.57. The business has a 50 day simple moving average of $81.03 and a two-hundred day simple moving average of $75.09.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the company posted $1.13 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Wall Street Analyst Weigh In

CTVA has been the subject of a number of recent analyst reports. Oppenheimer boosted their target price on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Royal Bank Of Canada boosted their target price on Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Wells Fargo & Company boosted their target price on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 21st. Deutsche Bank Aktiengesellschaft boosted their target price on Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Finally, Morgan Stanley boosted their target price on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, Corteva has an average rating of “Moderate Buy” and a consensus price target of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.